Scarica l'app Stockscreener
74.76
0.54%
0.40
Dopo l'orario di chiusura:
74.76
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$74.36
Aprire:
$74.27
Volume 24 ore:
4.94M
Relative Volume:
1.61
Capitalizzazione di mercato:
$16.66B
Reddito:
$4.04B
Utile/perdita netta:
$557.10M
Rapporto P/E:
31.02
EPS:
2.4102
Flusso di cassa netto:
$916.70M
1 W Prestazione:
+0.84%
1M Prestazione:
+1.04%
6M Prestazione:
+37.73%
1 anno Prestazione:
-5.33%
Intervallo 1D:
$74.20
$74.86
Intervallo di 1 settimana:
$74.10
$74.86
Portata 52W:
$51.90
$80.31
Hologic Inc Stock (HOLX) Company Profile
Nome
Hologic Inc
Settore
Industria
Telefono
(508) 263-2900
Indirizzo
250 CAMPUS DRIVE, MARLBOROUGH, MA
Confronta HOLX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
74.76 | 16.58B | 4.04B | 557.10M | 916.70M | 2.4102 |
|
ISRG
Intuitive Surgical Inc
|
568.48 | 199.09B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
190.96 | 55.24B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
76.25 | 37.63B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
250.52 | 36.60B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
273.99 | 19.50B | 2.96B | 487.70M | 344.00M | 6.6758 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-21 | Downgrade | BNP Paribas Exane | Outperform → Neutral |
| 2025-10-07 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-08-18 | Aggiornamento | Argus | Hold → Buy |
| 2025-08-06 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-05-27 | Reiterato | Needham | Hold |
| 2025-03-03 | Downgrade | Argus | Buy → Hold |
| 2025-02-06 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | Downgrade | Needham | Buy → Hold |
| 2024-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2024-12-10 | Iniziato | Jefferies | Hold |
| 2024-12-10 | Reiterato | Needham | Buy |
| 2024-10-01 | Downgrade | Citigroup | Buy → Neutral |
| 2024-06-27 | Iniziato | Stephens | Overweight |
| 2024-04-03 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-07-14 | Aggiornamento | Needham | Hold → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-07-20 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-07-20 | Iniziato | UBS | Neutral |
| 2022-07-18 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2021-12-15 | Downgrade | Citigroup | Buy → Neutral |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-10-14 | Iniziato | Redburn | Neutral |
| 2021-07-06 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-11-20 | Downgrade | Needham | Buy → Hold |
| 2020-11-05 | Reiterato | Needham | Buy |
| 2020-06-30 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2020-06-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | Reiterato | Needham | Buy |
| 2020-04-30 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | Reiterato | Needham | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-09-26 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | Reiterato | Needham | Buy |
| 2019-05-02 | Reiterato | Needham | Buy |
| 2019-01-31 | Reiterato | Needham | Buy |
| 2019-01-02 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | Iniziato | UBS | Neutral |
| 2018-09-13 | Downgrade | BofA/Merrill | Buy → Neutral |
Mostra tutto
Hologic Inc Borsa (HOLX) Ultime notizie
What analysts say about Hologic Inc stockEarnings Call Summaries & Market Crushing Stock Picks - earlytimes.in
Should You Add RattanIndia Power Limited Stock to Your Portfolio Now - earlytimes.in
GE HealthCare to acquire Intelerad for $2.3B - Radiology Business
Halper Sadeh LLC Encourages FRGE, BHF, HOLX Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.
Hologic's GYN Surgical Delivers a Standout Quarter: What's Behind It? - sharewise.com
Here Are Friday’s Top Wall Street Analysts Research Calls: Advanced Micro Devices, Block, Broadcom, Exact Sciences, Hologic, Palo Alto Networks and More - Yahoo Finance
Does Hologic Inc. (HO1) stock trade below intrinsic value2025 Price Action Summary & Step-by-Step Trade Execution Guides - newser.com
Will Hologic Inc. (HO1) stock justify high valuation2025 Stock Rankings & Daily Entry Point Trade Alerts - newser.com
BNP Paribas Exane Downgrades Hologic to Neutral From Outperform, Adjusts PT to $79 From $75 - MarketScreener
Can Hologic Inc. (HO1) stock attract ESG investmentsRisk Management & Technical Pattern Alert System - newser.com
Here Are Friday's Top Wall Street Analysts Research Calls: Advanced Micro Devices, Block, Broadcom, Exact Sciences, Hologic, Palo Alto Networks and More - 24/7 Wall St.
Hologic About to Dominate Women’s Health? The Surge Behind Its Global Growth! - Smartkarma
Is a relief rally coming for Hologic Inc. holdersJuly 2025 Outlook & AI Enhanced Trading Signals - newser.com
Why the Narrative Around Hologic Is Changing After the Blackstone and TPG Acquisition News - Yahoo Finance
Why Hologic Inc. stock remains on buy listsJuly 2025 Pullbacks & Long-Term Growth Plans - newser.com
Is Hologic Inc. stock a dividend growth opportunityJuly 2025 Patterns & Fast Entry and Exit Trade Plans - newser.com
Will Hologic Inc. (HO1) stock benefit from Fed rate cutsJuly 2025 Big Picture & Low Risk High Win Rate Stock Picks - newser.com
Is Hologic Inc. (HO1) stock cheap vs fundamentalsAnalyst Upgrade & Weekly Return Optimization Plans - newser.com
Will Hologic Inc. (HO1) stock maintain strong growthProduct Launch & Weekly High Conviction Ideas - newser.com
Will Hologic Inc. stock maintain growth storyJuly 2025 Review & Weekly Watchlist for Consistent Profits - newser.com
Is Hologic Inc. (HO1) stock among top earnings plays2025 Institutional Moves & Verified Entry Point Signals - newser.com
Will Hologic Inc. (HO1) stock beat Nasdaq index returnsJuly 2025 Closing Moves & Safe Swing Trade Setup Alerts - newser.com
Using Ichimoku Cloud for Hologic Inc. technicalsWeekly Gains Report & Free Community Consensus Stock Picks - newser.com
3 Reasons HOLX is Risky and 1 Stock to Buy Instead - Finviz
How Hologic Inc. (HO1) stock compares with market leadersRate Cut & Safe Capital Growth Stock Tips - newser.com
Hologic Inc Azioni (HOLX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):